Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
-
Shadab century and record last-wicket stand carry Pakistan past England
-
Brazil's Lula clinches poll victory, Bolsonaro seeks to annul election
-
Baylor dismisses Dave Aranda and appoints Joe Klanderman interim coach
-
Doncic dominates for Lakers as James' Sixers fall to Pistons
-
Stocks sink as traders brace for tech earnings, central bank decisions
-
UP schools close for Valmiki Jayanti as coastal states monitor cyclone risk
-
Albert Zahn’s carved birds find a lasting home in Wisconsin museums
-
France's debt woes in focus as ECB meets
-
NPS Vatsalya offers three choices when a child turns 18
-
US midterm political advertising crosses $10 billion
-
China's Communist Party elite gather for governance talks
-
Data center next door divides old Massachusetts mill town
-
Maine logging, cross-border ties whipsawed by US-Canada tariff war
-
AI ad blitz distorts US midterms
-
From Carnegie to Claude: AI wealth could reshape philanthropy
-
Israel's Eisenkot vows unity as Netanyahu paints him as soft on Iran
-
India and Russia plan 2027 pilot voyages on Northern Sea Route
-
First international flight takes off from new Sydney airport
-
What challenges await Brazil's Lula in his fourth term?
-
Jio’s next phase turns attention from subscriber growth to returns
-
Brazil's Lula defies odds to clinch poll victory against Flavio Bolsonaro
-
Eric Ries sets out how mission-driven companies can endure
-
Falcons hand 49ers first defeat of NFL season, Vikings remain unbeaten
-
Book examines five forces driving the next phase of Indian startups
-
Readers debate YES Bank bonds, climate commitments and candidate disclosure
-
Lula, Bolsonaro in virtual tie halfway through Brazil vote count
-
Australian politicians pay tribute to wounded lawmaker
-
Antonelli looks to seal title 'in style' after US Grand Prix win
-
Modi opens RBI data centre and cybersecurity training institute
-
Real Madrid century 'just a detail' for Mbappe after Clasico win
-
Nifty heads toward weakest Samvat of Modi era after 13% fall
-
Mbappe double helps Real Madrid stun Barca in La Liga Clasico
-
Disappointed Verstappen admits to wrong tyre strategy at US Grand Prix
-
Antonelli wins US Grand but title triumph has to wait another week
-
India trims weekly wheat auction volume despite strong miller demand
-
Manchester United slump deepens as Liverpool climb with Brighton win
-
Brazil braces for result of knife-edge election after voting chaos
-
Reus sends Bordeaux second in Top 14 with victory at La Rochelle
-
Bleems adds UFFF toys and collectibles through Kuwait partnership
-
Serbia's student movement ousts longtime leader in parliament poll
-
Real Madrid beat Barcelona in La Liga Clasico
-
Kuwait minister urges focus on investment quality and development impact
-
Antonelli wins US Grand Prix to close on world title
-
Descendants of British slave-owning families support reparations campaign
-
Israel plans West Bank crossing shutdown for election day
-
Aleksandar Vucic: Serbia's veteran ruler felled by student-led movement
-
Falcons hand 49ers first defeat of NFL season
-
Obama attacks Trump record while campaigning in Ohio and Michigan
-
Kuwait regulators broaden beneficial-owner data cooperation
-
Brazil voting extended in tight race between Lula, Bolsonaro
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.
Company Webcast
The webcast presentation will take place at 9:15 a.m. Eastern time on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/8p9EoXv752z. The webcast will also be available for replay following the event. It will also be accessible on the Investors section of the Company's website at https://investors.aytubio.com/ under Events & Presentations.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at [email protected] or register for the event at https://lythampartners.com/spring2026invreg/.
About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), and treatments for attention deficit-hyperactivity disorder (ADHD). Aytu is committed to delivering the Company's medications through best-in-class patient access programs that help to enable optimal patient outcomes. For more information, please visit aytubio.com or follow us on LinkedIn.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
[email protected]
Robert Blum
Lytham Partners
[email protected]
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire
S.F.Warren--AMWN
